drugset / Trial / NCT03631563
ATG-F VS ATG for the Prevention of GVHD
RandomizedParallel-groupOpen-labelTreatment
Summary
Anti-thymocyte globulin (ATG) preparative regimen in the setting of haploidentical stem cell transplantation (haplo-HSCT) is vital for inducing immune tolerance.The study aims to compare the efficacy and safety of ATG-F vs ATG, incorporated into the preparative regimens for haplo-identical transplants.
Timeline
- Start
- 2013-03-01
- Primary completion
- 2018-12-01
- Completion
- 2020-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE) | Protein / enzyme biologic | — | — |
| Subject | Thymoglobulin | Protein / enzyme biologic | — | — |